Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Factors affecting drug concentrations and QT interval during thioridazine therapy.

Thanacoody RH, Daly AK, Reilly JG, Ferrier IN, Thomas SH.

Clin Pharmacol Ther. 2007 Nov;82(5):555-65. Epub 2007 Apr 25.

PMID:
17460606
2.

Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses.

Salih IS, Thanacoody RH, McKay GA, Thomas SH.

Clin Pharmacol Ther. 2007 Nov;82(5):548-54. Epub 2007 Apr 4.

PMID:
17410120
3.

Reversal of resistance in microorganisms by help of non-antibiotics.

Kristiansen JE, Hendricks O, Delvin T, Butterworth TS, Aagaard L, Christensen JB, Flores VC, Keyzer H.

J Antimicrob Chemother. 2007 Jun;59(6):1271-9. Epub 2007 Apr 2. Review.

4.

Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy.

Bustamante JM, Presti MS, Rivarola HW, Fernández AR, Enders JE, Fretes RE, Paglini-Oliva P.

Int J Antimicrob Agents. 2007 Jun;29(6):733-7. Epub 2007 Mar 28.

PMID:
17395432
5.

Estimating health care-associated infections and deaths in U.S. hospitals, 2002.

Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, Cardo DM.

Public Health Rep. 2007 Mar-Apr;122(2):160-6.

6.

In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis.

Martins M, Schelz Z, Martins A, Molnar J, Hajös G, Riedl Z, Viveiros M, Yalcin I, Aki-Sener E, Amaral L.

Int J Antimicrob Agents. 2007 Mar;29(3):338-40. Epub 2007 Jan 18.

PMID:
17239569
7.

Risk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: a population-based study.

Yang SY, Kao Yang YH, Chong MY, Yang YH, Chang WH, Lai CS.

Clin Pharmacol Ther. 2007 Apr;81(4):586-94. Epub 2007 Jan 18.

PMID:
17235331
8.

hERG K+ channel blockade by the antipsychotic drug thioridazine: An obligatory role for the S6 helix residue F656.

Milnes JT, Witchel HJ, Leaney JL, Leishman DJ, Hancox JC.

Biochem Biophys Res Commun. 2006 Dec 8;351(1):273-80. Epub 2006 Oct 23.

PMID:
17056009
9.

Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine.

Meissner PE, Mandi G, Coulibaly B, Witte S, Tapsoba T, Mansmann U, Rengelshausen J, Schiek W, Jahn A, Walter-Sack I, Mikus G, Burhenne J, Riedel KD, Schirmer RH, Kouyaté B, Müller O.

Malar J. 2006 Oct 8;5:84.

10.
11.

Searching for new antimalarial therapeutics amongst known drugs.

Weisman JL, Liou AP, Shelat AA, Cohen FE, Guy RK, DeRisi JL.

Chem Biol Drug Des. 2006 Jun;67(6):409-16.

12.

"Non-Antibiotics": alternative therapy for the management of MDRTB and MRSA in economically disadvantaged countries.

Amaral L, Viveiros M, Kristiansen JE.

Curr Drug Targets. 2006 Jul;7(7):887-91. Review.

PMID:
16842219
13.

Thioridazine reduces resistance of methicillin-resistant staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump.

Kristiansen MM, Leandro C, Ordway D, Martins M, Viveiros M, Pacheco T, Molnar J, Kristiansen JE, Amaral L.

In Vivo. 2006 May-Jun;20(3):361-6.

14.

Molecular determinants of HERG channel block.

Kamiya K, Niwa R, Mitcheson JS, Sanguinetti MC.

Mol Pharmacol. 2006 May;69(5):1709-16. Epub 2006 Feb 10.

15.
16.

The in vitro activity of phenothiazines against Mycobacterium avium: potential of thioridazine for therapy of the co-infected AIDS patient.

Viveiros M, Martins M, Couto I, Kristiansen JE, Molnar J, Amaral L.

In Vivo. 2005 Jul-Aug;19(4):733-6.

17.

Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs.

Weinstein EA, Yano T, Li LS, Avarbock D, Avarbock A, Helm D, McColm AA, Duncan K, Lonsdale JT, Rubin H.

Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4548-53. Epub 2005 Mar 14.

18.

In vitro activity of phenothiazine derivatives in Enterococcus faecalis and Enterococcus faecium.

Hendricks O, Molnar A, Butterworth TS, Butaye P, Kolmos HJ, Christensen JB, Kristiansen JE.

Basic Clin Pharmacol Toxicol. 2005 Jan;96(1):33-6.

19.

Clinical concentrations of thioridazine enhance the killing of intracellular methicillin-resistant Staphylococcus aureus: an in vivo, ex vivo and electron microscopy study.

Martins M, Bleiss W, Marko A, Ordway D, Viveiros M, Leandro C, Pacheco T, Molnar J, Kristiansen JE, Amaral L.

In Vivo. 2004 Nov-Dec;18(6):787-94.

20.

Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice.

Lo Presti MS, Rivarola HW, Bustamante JM, Fernández AR, Enders JE, Fretes R, Gea S, Paglini-Oliva PA.

Int J Antimicrob Agents. 2004 Jun;23(6):634-6.

PMID:
15194137
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk